Novo Nordisk combination diabetes drug effective after 1 yr-study

11:15 EDT 14 Jun 2014 | Reuters

June 14 (Reuters) - A Novo Nordisk drug combining its long-acting insulin degludec with its type 2 diabetes treatment Victoza maintained superior blood sugar reduction after one year than either medicine separately, according to data from a late stag...

Original Article: Novo Nordisk combination diabetes drug effective after 1 yr-study

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk combination diabetes drug effective after 1 yr-study"

Search BioPortfolio:
Advertisement

Relevant Topics

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Pharmacy
Latest News Clinical Trials Research Drugs Reports Corporate
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Advertisement

Searches Linking to this Story